• Leveljump Healthcare Corp. (JUMP) will not be proceeding with its purchase of Telehospital Corp.
  • The transaction was originally scheduled for the end of June, 2022
  • Leveljump Healthcare is a leader in business-to-business (B2B) telehealth solutions
  • LevelJump Healthcare Corp. (TSXV:JUMP) opened trading at C$0.075

Leveljump Healthcare Corp. (JUMP) will not be proceeding with its previously announced purchase of Telehospital Corp.

The transaction was initially scheduled to close at the end of June 2022, but the vendors demanded certain last-minute adjustments, which Leveljump did not accept.

Leveljump continues looking for acquisitions to complement and expand its existing operations.

Leveljump Healthcare is a leader in business-to-business (B2B) telehealth solutions.

LevelJump Healthcare Corp. (TSXV:JUMP) opened trading at C$0.075.

More From The Market Online

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.